Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
PI 3-Kinase p85 beta Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP141066
Description
PI 3-Kinase p85 beta Polyclonal specifically detects PI 3-Kinase p85 beta in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunoprecipitation.Specifications
PI 3-Kinase p85 beta | |
Polyclonal | |
Unconjugated | |
TBS and 0.1% BSA with 0.09% Sodium Azide | |
PIK3R2 | |
The immunogen for this product maps to a region between residue 75 and 125 of human phosphoinositide-3-kinase, regulatory subunit 2 using the numbering given in entry NP_005018.1 (GeneID 5296). | |
0.1 mL | |
Autophagy, Signal Transduction | |
5296 | |
Human | |
IgG |
Western Blot, Immunohistochemistry, Immunoprecipitation | |
0.2 mg/mL | |
Western Blot 1:2000-1:10000, Immunohistochemistry, Immunoprecipitation 5-15 ug/mg lysate | |
P85B, phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, phosphatidylinositol 3-kinase regulatory subunit beta, phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta), phosphoinositide-3-kinase, regulatory subunit 2 (beta), phosphoinositide-3-kinase, regulatory subunit 2 (p85 beta), phosphoinositide-3-kinase, regulatory subunit, polypeptide 2 (p85 beta), PI3K regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3-kinase subunit p85-beta, ptdIns-3-kinase regulatory subunit beta, ptdIns-3-kinase regulatory subunit p85-beta | |
Rabbit | |
Affinity Purified | |
RUO | |
Primary | |
Based on 100% sequence identity, this antibody is predicted to react with Orangutan, Rhesus Monkey, Gorilla, Chimpanzee, Crab-eating macaque and Northern white-cheeked gibbon. | |
Store at 4C. Do not freeze. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction